KOL on Demand: Case study discussion on semaglutide 2.4 mg
Play Video
Ildiko Lingvay 2015.jpg

The latest treatment for overweight/obesity, semaglutide 2.4 mg: Considerations and customization

To read the original printed case study, please click here.

Ildiko Lingvay, MD, MPH, MSCS

Professor of Medicine, University of Texas Southwestern Medical Center, Dallas

Copyright 2021 Health Monitor Network. All Rights Reserved.